Provided is a therapeutic agent for diseases associated with a cholinergic property of the central nervous system (CNS) and/or the peripheral nervous system (PNS), diseases associated with the contraction of smooth muscle, incretion diseases, diseases associated with neuronal degeneration and the like, said therapeutic agent comprising a compound represented by formula (I) [wherein X-Y-Z represents N-CO-NR